Table 1.
Dysfunction | Mechanism | Ref. |
---|---|---|
Increased oxidative stress and ROS | Impaired antioxidant ability results in mitochondria damage | [52] |
Abnormal expression of MMPs |
Decreased mRNA level and activity of MMP-2 and MMP-9 and increased TIMP-1 | [57] |
Decreased expression of MMP-1 and α2β1 integrin | [58] | |
Decreased expression of IL-22 may suppress production of MMP-3 in keratinocytes | [59] | |
Impaired proliferation and migration of KCs | Decreased expression of phosphorylated p125FAK | [57] |
Increased AGEs | [61] | |
Increased O-GlcNAc glycosylation and decreased expression of Gal-7 | [62] | |
Downregulated the p38/MAPK pathway followed by inactivation of autophagy | [76] | |
Increased percentage of M1 macrophage infiltration followed by increased secretion of TNF-α, which upregulates TIMP1 expression | [77] | |
Increased expression of FOXO1 stimulates the expression of MMP-9 | [7] | |
Impaired expression of K16 | [58] | |
Increased expression of suppressor of cytokine signaling-3 (SOCS-3) | [85] | |
Increased expression of Connexin 43 | [86] | |
Increased keratinocyte resistance to acetylcholine (Ach) | [91] | |
Chronic inflammation | Increased neutrophil and macrophage infiltration | [49] |
Increased pro-inflammatory cytokines (IL-1, IL-6, IL-8 and TNF-α) | [93] | |
Activation of the TNF-α and TLR4 signaling pathway | [95] | |
Decreased expression of Wnt family member 7A (wnt7a) | [97] | |
Increased expression of MIP-2 and MCP1 | [92] | |
Decreased COX-1 expression and increased COX-2 expression | [98] | |
Chronic infection | Reduced diversity of microbiota and promoted biofilm formation | [48] |
Bacteria directly influenced keratinocytes (increasing apoptosis, diminishing keratinocyte migration and proliferation) | [103] | |
Decreasing mRNA and protein levels of human β-defensins-2 (HBD-2) and HBD-3 | [104] | |
Decreased expression of mRNA and protein of cathelicidin | [107] | |
Impaired angiogenesis |
Impaired the recruitment and migration of endothelial cells and EPCs | [112] |
Increased the expression of Thrombospondin-1 (TSP-1) | [114] | |
Decreased the expression of vascular endothelial growth factor (VEGF) | [116] |